Literature DB >> 26246098

Cerebral cavernous malformations associated to meningioma: High penetrance in a novel family mutated in the PDCD10 gene.

Francesco Garaci1, Luisa Marsili2, Florence Riant3, Simone Marziali4, Michaelle Cécillon5, Roberto Pasquarelli6, Federica Sangiuolo2, Roberto Floris1, Giuseppe Novelli2, Elisabeth Tournier-Lasserve3, Francesco Brancati7.   

Abstract

Multiple familial meningiomas occur in rare genetic syndromes, particularly neurofibromatosis type 2. The association of meningiomas and cerebral cavernous malformations (CCMs) has been reported in few patients in the medical literature. The purpose of our study is to corroborate a preferential association of CCMs and multiple meningiomas in subjects harbouring mutations in the PDCD10 gene (also known as CCM3). Three members of an Italian family affected by seizures underwent conventional brain Magnetic Resonance Imaging (MRI) with gadolinium contrast agent including gradient echo (GRE) imaging. The three CCM-causative genes were sequenced by Sanger method. Literature data reporting patients with coexistence of CCMs and meningiomas were reviewed. MRI demonstrated dural-based meningioma-like lesions associated to multiple parenchymal CCMs in all affected individuals. A disease-causative mutation in the PDCD10 gene (p.Gln112PhefsX13) was identified. Based on neuroradiological and molecular data as well as on literature review, we outline a consistent association between PDCD10 mutations and a syndrome of CCMs with multiple meningiomas. This condition should be considered in the differential diagnosis of multiple/familial meningioma syndromes. In case of multiple/familial meningioma the use of appropriate MRI technique may include GRE and/or susceptibility-weighted imaging (SWI) to rule out CCM. By contrast, proper post-gadolinium scans may aid defining dural lesions in CCM patients and are indicated in PDCD10-mutated individuals.
© The Author(s) 2015.

Entities:  

Keywords:  Magnetic resonance imaging; PDCD10.; cerebral cavernous malformation; multiple meningioma

Mesh:

Substances:

Year:  2015        PMID: 26246098      PMCID: PMC4757286          DOI: 10.1177/1971400915591688

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  15 in total

Review 1.  Brain tumors.

Authors:  L M DeAngelis
Journal:  N Engl J Med       Date:  2001-01-11       Impact factor: 91.245

2.  CCM3 Mutations Are Associated with Early-Onset Cerebral Hemorrhage and Multiple Meningiomas.

Authors:  F Riant; F Bergametti; H-D Fournier; F Chapon; S Michalak-Provost; M Cecillon; P Lejeune; H Hosseini; C Choe; M Orth; C Bernreuther; G Boulday; C Denier; P Labauge; E Tournier-Lasserve
Journal:  Mol Syndromol       Date:  2013-04-03

3.  Value of gradient-echo magnetic resonance imaging in the diagnosis of familial cerebral cavernous malformation.

Authors:  Fritz-Georg Lehnhardt; Ulrich von Smekal; Benedikt Rückriem; Werner Stenzel; Michael Neveling; Wolf-Dieter Heiss; Andreas H Jacobs
Journal:  Arch Neurol       Date:  2005-04

Review 4.  Meningioma.

Authors:  Christine Marosi; Marco Hassler; Karl Roessler; Michele Reni; Milena Sant; Elena Mazza; Charles Vecht
Journal:  Crit Rev Oncol Hematol       Date:  2008-03-14       Impact factor: 6.312

Review 5.  Meningiomas.

Authors:  Ian R Whittle; Colin Smith; Parthiban Navoo; Donald Collie
Journal:  Lancet       Date:  2004-05-08       Impact factor: 79.321

6.  Multiple dural lesions mimicking meningiomas in patients with CCM3/PDCD10 mutations.

Authors:  P Labauge; B Fontaine; J-P Neau; F Bergametti; F Riant; A Blecon; F Marchelli; M Arnoult; A Lannuzel; M Clanet; S Olschwang; C Denier; E Tournier-Lasserve
Journal:  Neurology       Date:  2009-06-09       Impact factor: 9.910

7.  Predictive genetic testing of at-risk relatives requires analysis of all CCM genes after identification of an unclassified CCM1 variant in an individual affected with cerebral cavernous malformations.

Authors:  Winnie Schröder; Juliane Najm; Stefanie Spiegler; Martina Mair; Julio Viera; Wolfram Henn; Ute Felbor
Journal:  Neurosurg Rev       Date:  2013-05-31       Impact factor: 3.042

8.  The natural history of familial cavernous malformations: results of an ongoing study.

Authors:  J M Zabramski; T M Wascher; R F Spetzler; B Johnson; J Golfinos; B P Drayer; B Brown; D Rigamonti; G Brown
Journal:  J Neurosurg       Date:  1994-03       Impact factor: 5.115

9.  Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study.

Authors:  Rustam Al-Shahi Salman; Julie M Hall; Margaret A Horne; Fiona Moultrie; Colin B Josephson; Jo J Bhattacharya; Carl E Counsell; Gordon D Murray; Vakis Papanastassiou; Vaughn Ritchie; Richard C Roberts; Robin J Sellar; Charles P Warlow
Journal:  Lancet Neurol       Date:  2012-01-31       Impact factor: 44.182

10.  Genomic profiling distinguishes familial multiple and sporadic multiple meningiomas.

Authors:  Yiping Shen; Fabio Nunes; Anat Stemmer-Rachamimov; Marianne James; Gayatry Mohapatra; Scott Plotkin; Rebecca A Betensky; David A Engler; Jennifer Roy; Vijaya Ramesh; James F Gusella
Journal:  BMC Med Genomics       Date:  2009-07-09       Impact factor: 3.063

View more
  3 in total

Review 1.  Cerebral Cavernous Malformations: Review of the Genetic and Protein-Protein Interactions Resulting in Disease Pathogenesis.

Authors:  Jacob F Baranoski; M Yashar S Kalani; Colin J Przybylowski; Joseph M Zabramski
Journal:  Front Surg       Date:  2016-11-14

2.  Familial Multiple Cavernous Malformation Syndrome: MR Features in This Uncommon but Silent Threat.

Authors:  Marc Mespreuve; Filip Vanhoenacker; Marc Lemmerling
Journal:  J Belg Soc Radiol       Date:  2016-03-21       Impact factor: 1.894

3.  Endothelial cell clonal expansion in the development of cerebral cavernous malformations.

Authors:  Matteo Malinverno; Claudio Maderna; Abdallah Abu Taha; Monica Corada; Fabrizio Orsenigo; Mariaelena Valentino; Federica Pisati; Carmela Fusco; Paolo Graziano; Monica Giannotta; Qing Cissy Yu; Yi Arial Zeng; Maria Grazia Lampugnani; Peetra U Magnusson; Elisabetta Dejana
Journal:  Nat Commun       Date:  2019-06-24       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.